Rare Diseases
Conference Coverage
Dr. Lisa Christopher-Stine: Polymyositis? It’s more likely something else
Thinking polymyositis? Look closely for IMNM, overlap with other rheumatologic conditions, antisynthetase syndrome, inclusion body myositis, and...
Literature Review
Clinical benefits persist 5 years after thymectomy for myasthenia gravis
Patients with generalized nonthymomatous myasthenia gravis who undergo thymectomy may have better long-term clinical outcomes and require less...
Daily News Podcast
Aspirin and Omega-3 fatty acids fail
Flu activity is ‘high’ in nine states.
From the Journals
Check for neuromyelitis optica spectrum disorder in suspect HIV patients
Daily News Podcast
Parental leave for residents
Social media can help you stay up-to-date: advice on how to use it.
Conference Coverage
What constitutes a clinically meaningful reduction in seizure frequency?
NEW ORLEANS – An analysis of clinical trial data suggests that a 44% reduction in seizure frequency is clinically...
Feature
Huntington’s research returns to Latin America, as scientists tread with care
Poor people in Latin America contributed to some of the biggest discoveries in Huntington’s disease research. Scientists want to work with them...
FDA/CDC
Firdapse approved: First treatment for rare autoimmune disorder
Amifampridine (Firdapse) has been approved by the FDA for Lambert-Eaton myasthenic syndrome, which affects the nerves’ connection with muscles.
FDA/CDC
CDC: No medical therapy can yet be recommended for acute flaccid myelitis
Updated guidelines find no solid evidence behind any treatment, all which must still be considered anecdotal.
From the Journals
AEDs strongly linked to rare serious skin reactions
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.